Portacaval shunt

From WikiMD's Medical Encyclopedia

Revision as of 14:29, 25 February 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Portacaval shunt is a surgical procedure that creates a connection between the portal vein and the inferior vena cava, which are two major blood vessels in the abdomen. This procedure is typically performed to reduce high blood pressure in the portal vein (a condition known as portal hypertension) that can occur as a result of liver disease.

Indications

Portacaval shunt is primarily indicated for patients with severe portal hypertension, often due to cirrhosis of the liver. This condition can lead to life-threatening complications such as esophageal varices and gastrointestinal bleeding. The shunt can help to reduce the pressure in the portal vein and prevent these complications.

Procedure

During a portacaval shunt procedure, the surgeon makes an incision in the abdomen and locates the portal vein and the inferior vena cava. A connection is then created between these two vessels, allowing blood to flow from the portal vein directly into the inferior vena cava. This bypasses the liver, reducing the pressure in the portal vein.

Risks and Complications

As with any surgical procedure, a portacaval shunt carries some risks. These can include infection, bleeding, and complications related to anesthesia. In addition, there is a risk of hepatic encephalopathy, a condition that can cause confusion and other neurological symptoms due to the buildup of toxins in the blood that are normally removed by the liver.

See Also

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.